ArticleInternal medicine (Tokyo, Japan)2018

Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease.

Satoshi Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.